ACRAL LENTIGINOUS MELANOMA
Clinical trials for ACRAL LENTIGINOUS MELANOMA explained in plain language.
Never miss a new study
Get alerted when new ACRAL LENTIGINOUS MELANOMA trials appear
Sign up with your email to follow new studies for ACRAL LENTIGINOUS MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Spinal immunotherapy injection shows promise for tough brain cancers
Disease control Recruiting nowThis early-phase study tests a combination of two ways to give the immunotherapy drug nivolumab: through a vein and directly into the fluid around the spine. It is for people with melanoma or lung cancer that has spread to the lining of the brain or spinal cord (leptomeningeal di…
Matched conditions: ACRAL LENTIGINOUS MELANOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New hope for brain metastases: Two-Drug combo vs Three-Drug combo in melanoma trial
Disease control Recruiting nowThis study tests two different drug combinations in people with BRAF-V600 mutant melanoma that has spread to the brain. One group gets a three-drug mix (encorafenib, binimetinib, and nivolumab), the other gets two immunotherapy drugs (ipilimumab and nivolumab). The goal is to see…
Matched conditions: ACRAL LENTIGINOUS MELANOMA
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 13, 2026 15:59 UTC